Black Rock Inc. Genetron Holdings LTD Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.8 - $1.12 $399,732 - $559,624	-499,665 Reduced 98.41%	8,050 $9,000
Q3 2022 Nov 14, 2022	SELL	$0.91 - $1.69 $13,762 - $25,559	-15,124 Reduced 2.89%	507,715 $397,000
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.4 $172,124 - $322,732	-134,472 Reduced 20.46%	522,839 $889,000
Q1 2022 May 12, 2022	SELL	$2.19 - $6.09 $315,859 - $878,348	-144,228 Reduced 17.99%	657,311 $1.44 Million
Q4 2021 Feb 10, 2022	BUY	$5.81 - $14.39 $1.64 Million - $4.05 Million	281,564 Added 54.15%	801,539 $4.89 Million
Q3 2021 Nov 09, 2021	SELL	$11.55 - $20.3 $6.89 Million - $12.1 Million	-596,699 Reduced 53.44%	519,975 $7.2 Million
Q2 2021 Aug 11, 2021	BUY	$17.9 - $23.29 $20 Million - $26 Million	1,116,674 New	1,116,674 $22.5 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.